The advertisement promotes VYVGART Hydrulo, highlighting it as the first and only IgG Fc-antibody fragment, while also providing important safety information and contraindications related to its use.
Creative Information
| CID: | 6c857624-27ba-4fa8-9e96-91a103d7c12d |
| CRID: | 82_5970-959619 |
| Domain: | vyvgarthcp.com |
| Seat: | PP |
| Size: | 728x90 |
| Bid: | $0.23 |
| Timestamp: | 11/28/2025, 2:49:50 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 12/10/2025, 4:49:28 AM | 6.67s | |
| adomain_analysis | success | 12/10/2025, 5:37:37 AM | 9.29s | |
| adomain_capture | success | 12/10/2025, 5:37:08 AM | 0.10s | |
| ad_render | success | 12/10/2025, 4:49:22 AM | 23.70s | |
| brand_mapping | success | 12/9/2025, 5:03:27 PM | 0.22s | |
Analysis Results
Ad Format: banner
Brands: VYVGART Hytrulo
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1088.42 KB | ||||||||||||||||||||||
| Render Time: | 8.28 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1156.86 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives
